PARP Inhibitors Market Share & Growth Analysis, 2032

ha aggiunto una foto Altre informazioni

2026-01-22 11:16:27

PARP Inhibitors Market Share & Growth Analysis, 2032 | UnivDatos

According to UnivDatos, the PARP inhibitors market was valued at USD 4,723.5 million in 2023 and is projected to grow at a robust CAGR of approximately 12.9% during the forecast period (2024–2032), driven largely by rising investments in PARP inhibitor research and development. Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as a breakthrough class of oncology therapeutics,...

0 Commenti 0 condivisioni 61 Views 0 Anteprima